Skip to main content
PRIMR24 Main banner
Icon Legend
Presentation Icons
Human Subject Research - HSR
Human Subject Research - HSR
ACU/IACUC
ACU/IACUC
Institutional Leadership
Institutional Leadership
Crossover
Crossover
Live Streamed Session
Live Streamed Session
Live Session Recorded
Live Session Recorded
Pre-Reg Required
Pre-Reg Required
Additional Fee
Additional Fee
On-Demand Session
On-Demand Session
CIP Accredited
CIP Accredited
CPIA Accredited
CPIA Accredited
Workshop Series
Workshop Series
Thought Leader Series
Thought Leader Series
Deep Dive Series
Deep Dive Series
Learning Lab Series
Learning Lab Series
Networking Series
Networking Series
Vendor Insight Series
Vendor Insight Series
Pillars of PRIM&R Poster Award
Pillars of PRIM&R Poster Award
Call for Session Proposal - CSP
Call for Session Proposal - CSP

  1. Home

  • Monday, Nov 18th
    10:30 AM – 11:45 AM PT
    A20 - How Institutional Leaders Can Promote COI Program Effectiveness
    Location: Room 331
    Panelist: Stacy Pritt, MS, DVM, MBA, CPIA, CHRC, DACAW (she/her/hers) – Texas A&M University System
    Speaker: Laura M. Evans, MA, CIP (she/her/hers) – Johns Hopkins University
    Speaker: Erika McCarthy, MA, CCRP (she/her/hers) – Memorial Sloan Kettering Cancer Center
    Education, Qualifications, and TrainingShared Research Oversight ChallengesLegal Considerations in Research Oversight
  • Monday, Nov 18th
    1:45 PM – 3:00 PM PT
    B17 - Effectively Managing the Use of Controlled Substances in Research
    Location: Room 445-446
    Speaker: Amy Kuei-Lan Chuang, MS,, RQAP-GLP, CPIA (she/her/hers) – Virginia Commonwealth University
    Speaker: Kelli Christman, MHA (she/her/hers) – University of Michigan
    Speaker: Joshua L. West, B.S. (he/him/his) – University of Michigan
    Education, Qualifications, and TrainingHRPP/IRB Management and AdministrationACU/IACUC Program Management and AdministrationShared Research Oversight ChallengesResearch Oversight Leaders and Institutional OfficialsLegal Considerations in Research OversightPharma/Biotech Perspectives
  • Tuesday, Nov 19th
    10:30 AM – 11:45 AM PT
    D01 - PLENARY: Responsibility Does Not End With Death: Establishing Systems for Ethical Decedent Research
    Location: Signature Room
    Moderator: Robert S. Salzar, PhD (he/him/his) – Center for Applied Biomechanics, Department of Mechanical and Aerospace Engineering, University of Virginia
    Panelist: Carson Cancel, MA, CIP – OHARO, USAMRDC
    Panelist: Sara Sochor, MS, CST, FSL, CAISS, CTBS – UVA Center for Applied Biomechanics
    Panelist: Paul Micah Johnson, PhD – FBI
    Legal Considerations in Research OversightEmerging Research Challenges and Breaking IssuesIRB Review
  • Tuesday, Nov 19th
    1:45 PM – 3:00 PM PT
    E19 - Balancing Risk and Reward in Research Programs
    Location: Room 445-446
    Speaker: Julie Ozier, MHL, CHRC, CIP – Advarra, Inc.
    Speaker: George Gasparis – The PEER Consulting Group
    ACU/IACUC Program Management and AdministrationHRPP/IRB Management and AdministrationResearch Oversight Leaders and Institutional OfficialsShared Research Oversight ChallengesLegal Considerations in Research Oversight
  • Tuesday, Nov 19th
    1:45 PM – 3:00 PM PT
    E16 - Done Wrong, Gotta Pay: Research Non-compliance and Research Misconduct and Possible Sponsor Pay-Back
    Location: Room 431-432
    Speaker: John R. Baumann, PhD (he/him/his) – formerly of Indiana University
    Education, Qualifications, and TrainingHRPP/IRB Management and AdministrationACU/IACUC Program Management and AdministrationShared Research Oversight ChallengesResearch Oversight Leaders and Institutional OfficialsLegal Considerations in Research Oversight
  • Tuesday, Nov 19th
    3:30 PM – 4:45 PM PT
    F16 - Plenary: Conducting Research "With" and "Not On" Indigenous Populations
    Location: Room 336
    Moderator: Cynthia R. Pearson, PhD – University of Washington
    Panelist: Myra Elizabeth Parker, JD, MPH, PhD (she/her/hers) – University of Washington School of Medicine
    Panelist: Terry J. M Powell, BBA – Alaska Area IRB
    Advancing Equity and JusticeEducation, Qualifications, and TrainingLegal Considerations in Research OversightShared Research Oversight Challenges
  • Tuesday, Nov 19th
    3:30 PM – 4:45 PM PT
    F19 - Proposed Changes to the Public Health Policy (PHS) on Research Misconduct: Impact on the Researcher Community
    Location: Room 333-334
    Speaker: Sheila Garrity, JD, MPH, MBA (she/her/hers) – Office of Assistant Secretary for Health
    Speaker: Jane Strasser, PhD (she/her/hers) – University of Cincinnati
    ACU/IACUC Program Management and AdministrationHRPP/IRB Management and AdministrationResearch Oversight Leaders and Institutional OfficialsShared Research Oversight ChallengesLegal Considerations in Research Oversight
  • Tuesday, Nov 19th
    3:30 PM – 4:45 PM PT
    F20 - Developing an Emergency Preparedness Plan for an Effective Research System
    Location: Room 335
    Speaker: Martha F. Jones, MA, CIP – Mass General Brigham Incorporated
    Speaker: Glenn Martin, MD CIP (he/him/his) – Icahn School of Medicine at Mount Sinai
    ACU/IACUC Program Management and AdministrationHRPP/IRB Management and AdministrationResearch Oversight Leaders and Institutional OfficialsShared Research Oversight ChallengesLegal Considerations in Research Oversight
  • Wednesday, Nov 20th
    10:30 AM – 11:45 AM PT
    H06 - What Are You Going To Do With My Specimens and Data? When Research Specimens and Data are Used for Commercial Profit
    Location: Signature Room
    Speaker: Madeleine Williams, MA, CIP – Huron Consulting Group
    Speaker: Marianna J. Bledsoe, M.A. – BIopreservation & Biobanking
    Speaker: Annette Schmid, PhD (she/her/hers) – Takeda
    Speaker: Rita T. Lawlor – ARC-Net and Department of Engineering for Innovative Medicine, University of Verona, Italy
    Research Involving Data and New TechnologiesLegal Considerations in Research OversightIRB ReviewPharma/Biotech Perspectives